CXCL13 has been shown to act as a chemoattractant to CD8+ and CD4+ T cells, and B cells in NSCLC, hence able to increase leukocyte presence in the area of secretion (Guo et al., 2017). This evidence concerns the gene CD8A and non-small cell lung carcinoma.